Expanded access to nirogacestat for serious conditions
Treatments studied
Part of Cancer clinical trials.
This program provides access to an unapproved drug called nirogacestat for patients with serious conditions who have run out of standard treatment options. It is designed for compassionate use when no other trial is available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a serious or life-threatening medical condition.
- Your condition cannot be helped by any approved medication or standard treatment, or you have already tried all available options.
- You are not eligible for any other ongoing clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called nirogacestat to see if it can help premenopausal women with desmoid tumors (a type of non-cancerous growth) that are causing symptoms or getting worse. It aims to offer a new treatment option for those who need systemic therapy.
This Phase 2 study tests whether combining cryoablation (freezing the tumor) with nirogacestat (a targeted pill treatment) can better control desmoid tumors that are growing or causing symptoms. It may help shrink tumors and improve symptoms, especially when freezing alone is challenging.
This program provides access to an investigational drug called mirdametinib for people with serious, debilitating, or life-threatening conditions who have no other treatment options and cannot join a clinical trial. It aims to offer a potential treatment when nothing else has worked.
This trial offers expanded access to an experimental treatment (RZ-001) for people with recurrent glioblastoma (a type of brain cancer) that has grown again after initial treatment. It is for those who cannot join other clinical trials and aims to provide possible treatment options when standard ones have failed.
This Phase 2 study tests nirogacestat (a targeted medicine) in people with desmoid tumors that are growing. It also studies how tumors respond—or don’t respond—by using repeated tumor scans and sometimes repeated tumor biopsies.
This program provides early access to two experimental cancer drugs, botensilimab and balstilimab, for patients with serious or life-threatening conditions who have no other treatment options and cannot join a clinical trial.
Hear when a new Desmoid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.